Breaking News Instant updates and real-time market news.

2022-05-20 12:09:57 GPI Group 1 Automotive $176.04 / -3.66 (-2.04%) 12:09 05/20/22 05/20 12:09 05/20/22 12:09	Group 1 Automotive downgraded to Underweight from Equal Weight at Morgan Stanley Morgan Stanley analyst Adam Jonas downgraded Group 1 Automotive to Underweight from Equal Weight with a $160 price target.	25 May

2022-05-20 12:09:57

GPI

Group 1 Automotive

$176.04 / -3.66 (-2.04%)

12:09

05/20/22

05/20

12:09

05/20/22

12:09

Group 1 Automotive downgraded to Underweight from Equal Weight at Morgan Stanley

Morgan Stanley analyst Adam Jonas downgraded Group 1 Automotive to Underweight from Equal Weight with a $160 price target.

25
May

OTHER BREAKING NEWS FROM THE FLY

Initiation	Haleon initiated with a Sector Perform at RBC Capital » 12:01 08/15/22 08/15 12:01 08/15/22 12:01 HLN Haleon $6.35 / -0.345 (-5.15%) , PFE Pfizer $49.55 / -0.55 (-1.10%) , GSK GSK plc $34.55 / -1.495 (-4.15%) RBC Capital analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HLN PFE GSK HLN Haleon $6.35 / -0.345 (-5.15%) 08/11/22 Haleon says it is not a party to any Zantac claims 08/11/22 GSK says no new 'material developments' related to Zantac litigation 07/18/22 GSK plc announces completion of demerger of Haleon PFE Pfizer $49.55 / -0.55 (-1.10%) 09:31 Today Pfizer Chairman, CEO Bourla tests positive for COVID-19 08/12/22 Pfizer reports 'positive' results from Phase 3 study of 20vPnC 08/11/22 Haleon says it is not a party to any Zantac claims 08/11/22 Sanofi says 'confident in its legal defenses' related to U.S. Zantac litigation GSK GSK plc $34.55 / -1.495 (-4.15%) 09:49 Today Ideaya Biosciences down 34% after GSK waived option on IDE397 08/11/22 Haleon says it is not a party to any Zantac claims 08/11/22 GSK says no new 'material developments' related to Zantac litigation 08/11/22 Sanofi says 'confident in its legal defenses' related to U.S. Zantac litigation HLN PFE GSK HLN Haleon $6.35 / -0.345 (-5.15%) 08/12/22 JPMorgan Sanofi may not be liable for any Zantac litigation damages, says JPMorgan 08/11/22 JPMorgan Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan 08/11/22 Deutsche Bank Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank 07/29/22 Deutsche Bank Haleon initiated with a Hold at Deutsche Bank PFE Pfizer $49.55 / -0.55 (-1.10%) 08/14/22 BofA Pfizer Prevnar-20 miss on co-primary endpoint could help Vaxcyte, says BofA 08/12/22 JPMorgan Sanofi may not be liable for any Zantac litigation damages, says JPMorgan 08/11/22 JPMorgan Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan 08/11/22 Deutsche Bank Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank GSK GSK plc $34.55 / -1.495 (-4.15%) 10:20 Today Stifel Ideaya Biosciences downgraded to Hold at Stifel after GSK waives IDE397 opt-in 08/12/22 JPMorgan Sanofi may not be liable for any Zantac litigation damages, says JPMorgan 08/11/22 JPMorgan Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan 08/11/22 Deutsche Bank Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank PFE GSK PFE Pfizer $49.55 / -0.55 (-1.10%) 07/28/22 Pfizer raises FY22 adjusted EPS view to $6.30-$6.45 from $6.25-$6.45 07/28/22 Pfizer reports Q2 adjusted EPS $2.04, consensus $1.80 07/27/22 Notable companies reporting before tomorrow's open 07/27/22 Notable companies reporting before tomorrow's open GSK GSK plc $34.55 / -1.495 (-4.15%) 07/27/22 GSK plc reports Q2 adjusted EPS 34.7p vs. 28.2p last year 04/27/22 GlaxoSmithKline reaffirms FY22 sales growth between 5%-7% at CER 04/27/22 GlaxoSmithKline reports Q1 adjusted EPS 32.8p vs. 22.9p last year 04/13/22 GlaxoSmithKline backs FY22 revenue view up 5%-7% at CER, consensus $47.34B HLN PFE GSK HLN Haleon $6.35 / -0.345 (-5.15%) 08/11/22 GSK, Sanofi weakness related to Zantac litigation worries, Bloomberg reports PFE Pfizer $49.55 / -0.55 (-1.10%) 08/05/22 Pfizer in advanced talks to buy Global Blood for about $5B, WSJ reports 08/05/22 Pfizer in talks to buy Global Blood Therapeutics for about $5B, WSJ says 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports 06/28/22 FDA panel recommends omicron update for COVID vaccine boosters, CNBC says GSK GSK plc $34.55 / -1.495 (-4.15%) 08/11/22 GSK, Sanofi weakness related to Zantac litigation worries, Bloomberg reports 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports 06/27/22 GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says 06/27/22 GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says HLN PFE GSK HLN Haleon $6.35 / -0.345 (-5.15%) 08/11/22 Renewed Zantac litigation concerns sinking these big-cap drugmakers 08/11/22 What You Missed On Wall Street This Morning 07/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 What You Missed On Wall Street This Morning PFE Pfizer $49.55 / -0.55 (-1.10%) 08/11/22 Renewed Zantac litigation concerns sinking these big-cap drugmakers 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Fly Intel: Pre-market Movers GSK GSK plc $34.55 / -1.495 (-4.15%) 08/11/22 What You Missed On Wall Street On Thursday 08/11/22 Renewed Zantac litigation concerns sinking these big-cap drugmakers 08/11/22 What You Missed On Wall Street This Morning 08/09/22 What You Missed On Wall Street On Tuesday 09/10/22 ESMO Congress 2022 HLN PFE GSK HLN Haleon $6.35 / -0.345 (-5.15%) 07/27/22 new option listings and one option delisting on July 27th PFE Pfizer $49.55 / -0.55 (-1.10%) 08/11/22 Pfizer call volume above normal and directionally bullish 07/28/22 Unusually active option classes on open July 28th 06/30/22 Early notable gainers among liquid option names on June 30th 05/20/22 Early notable gainers among liquid option names on May 20th GSK GSK plc $34.55 / -1.495 (-4.15%) 09:40 Today Unusually active option classes on open August 15th 08/12/22 Unusually active option classes on open August 12th 08/11/22 GSK plc (ADR) call volume above normal and directionally bullish 08/10/22 GSK plc (ADR) call volume above normal and directionally bullish
Recommendations	Russel Metals price target raised to C$42 from C$39 at RBC Capital » 12:01 08/15/22 08/15 12:01 08/15/22 12:01 RUSMF Russel Metals $23.20 / +0.67 (+2.97%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research RUSMF Russel Metals $23.20 / +0.67 (+2.97%) 11:09 Today Scotiabank Russel Metals price target lowered to C$37.50 from C$38.50 at Scotiabank 08/12/22 BMO Capital Russel Metals price target lowered to C$32 from C$36 at BMO Capital 08/12/22 Stifel Russel Metals price target raised to C$40 from C$34 at Stifel 07/18/22 RBC Capital Russel Metals price target lowered to C$39 from C$45 at RBC Capital
Conference/Events	Cantor Fitzgerald equity derivative analyst has analyst/industry conference call » 12:01 08/15/22 08/15 12:01 08/15/22 12:01 Equity Derivatives and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Northland Power price target raised to C$48 from C$46 at RBC Capital » 12:01 08/15/22 08/15 12:01 08/15/22 12:01 NPIFF Northland Power $35.76 / +1.22 (+3.53%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research NPIFF Northland Power $35.76 / +1.22 (+3.53%) 07/11/22 Northland Power signs corporate power purchase agreement 05/17/22 Northland Power announces amendment to diversity policy 05/09/22 BNP Paribas, Northland Power partner with Export Development Canada 04/27/22 Northland Power launches refreshed brand NPIFF Northland Power $35.76 / +1.22 (+3.53%) 11:30 Today National Bank Northland Power price target raised to C$49 from C$47 at National Bank 11:04 Today Scotiabank Northland Power price target raised to C$51 from C$46.25 at Scotiabank 10:53 Today TD Securities Northland Power price target raised to C$55 from C$47 at TD Securities 08/12/22 BMO Capital Northland Power price target raised to C$50 from C$44 at BMO Capital
Recommendations	MDA Ltd price target lowered to C$13 from C$15 at RBC Capital » 12:01 08/15/22 08/15 12:01 08/15/22 12:01 MDALF MDA Ltd / + RBC Capital analyst Ken… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research MDALF MDA Ltd / + 07/07/22 MDA appoints Johnson as Vice President of RSO MDALF MDA Ltd / + 05/12/22 BMO Capital MDA Ltd price target lowered to C$11 from C$13 at BMO Capital 05/12/22 Canaccord MDA Ltd price target lowered to C$15 from C$20 at Canaccord 03/18/22 Canaccord MDA Ltd price target lowered to C$20 from C$21 at Canaccord 03/18/22 RBC Capital MDA Ltd price target raised to C$15 from C$13 at RBC Capital
Recommendations	H&R REIT price target raised to C$15.75 from C$15 at RBC Capital » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 HRUFF H&R REIT $10.86 / +0.21 (+1.97%) RBC Capital analyst Matt… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HRUFF H&R REIT $10.86 / +0.21 (+1.97%) 11:37 Today National Bank H&R REIT price target raised to C$16.50 from C$15.25 at National Bank 07/20/22 National Bank H&R REIT price target lowered to C$15.25 from C$18.50 at National Bank 05/18/22 Scotiabank H&R REIT price target raised to C$16.50 from C$15.25 at Scotiabank 05/16/22 BMO Capital H&R REIT price target raised to C$18 from C$16 at BMO Capital
Hot Stocks	Redwire falls -9.9% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 RDW Redwire $3.57 / -0.35 (-8.93%) Redwire is down -9.9%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options RDW Redwire $3.57 / -0.35 (-8.93%) 07/01/22 Redwire added to broad-market Russell 3000 Index 06/07/22 Redwire awarded contract to manufacture link-16 antennas 06/01/22 Redwire CFO Bill Read to transition out of role, Jonathan Baliff to succeed 05/03/22 Redwire names Al Tadros Chief Technology Officer RDW Redwire $3.57 / -0.35 (-8.93%) 09/28/21 Fly Intel: Top five analyst initiations 09/28/21 Jefferies Redwire initiated with a Buy at Jefferies RDW Redwire $3.57 / -0.35 (-8.93%) 05/12/22 Redwire reports Q1 EPS (28c) vs. (21c) last year 03/31/22 Redwire sees FY22 revenue $165M-$195M vs. $96.8M in FY21 03/31/22 Redwire reports Q4 EPS (55c) vs. (6c) last year RDW Redwire $3.57 / -0.35 (-8.93%) 04/01/22 What You Missed On Wall Street On Friday 04/01/22 What You Missed On Wall Street This Morning 03/31/22 Fly Intel: After-Hours Movers RDW Redwire $3.57 / -0.35 (-8.93%) 03/23/22 Largest borrow rate increases among liquid names 03/15/22 Largest borrow rate increases among liquid names 03/14/22 Largest borrow rate increases among liquid names 03/11/22 Largest borrow rate increases among liquid names
Hot Stocks	Turquoise Hill falls -10.4% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 TRQ Turquoise Hill $23.56 / -2.68 (-10.21%) Turquoise Hill is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TRQ Turquoise Hill $23.56 / -2.68 (-10.21%) 10:00 Today Turquoise Hill falls -14.1% 09:47 Today Turquoise Hill falls -17.0% 09:19 Today Turquoise Hill down 17% after terminating review to be bought by Rio Tinto 06:37 Today Rio Tinto reiterates proposal for acquisition of Turquoise Hill TRQ Turquoise Hill $23.56 / -2.68 (-10.21%) 08/08/22 Canaccord Turquoise Hill price target lowered to C$42 from C$44 at Canaccord 08/08/22 TD Securities Turquoise Hill price target lowered to C$38 from C$40 at TD Securities 08/08/22 Canaccord Turquoise Hill price target lowered to C$42 from C$44 at Canaccord 07/14/22 Canaccord Turquoise Hill price target lowered to C$44 from C$45 at Canaccord TRQ Turquoise Hill $23.56 / -2.68 (-10.21%) 08/04/22 Turquoise Hill backs FY22 copper production guidance 08/04/22 Turquoise Hill reports Q2 EPS 51c, consensus 36c 05/10/22 Turquoise Hill reports Q1 EPS $1.37, consensus 28c TRQ Turquoise Hill $23.56 / -2.68 (-10.21%) 04/19/22 Fly Intel: After-Hours Movers 03/14/22 What You Missed On Wall Street On Monday 03/14/22 What You Missed On Wall Street This Morning
Hot Stocks	SmartRent falls -13.2% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 SMRT SmartRent $3.32 / -0.495 (-12.99%) SmartRent is down -13.2%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SMRT SmartRent $3.32 / -0.495 (-12.99%) 08/12/22 SmartRent falls -32.7% 08/12/22 SmartRent falls -26.6% 08/12/22 SmartRent falls -19.5% 08/11/22 SmartRent falls 28% to $4.02 after Q2 earnings miss and guidance cut SMRT SmartRent $3.32 / -0.495 (-12.99%) 08/12/22 Cantor Fitzgerald SmartRent price target lowered to $5.25 from $6.00 at Cantor Fitzgerald 07/22/22 Cantor Fitzgerald SmartRent assumed with an Overweight at Cantor Fitzgerald 07/19/22 Keefe Bruyette Bain Capital sold 5% of stake in SmartRent, says Keefe Bruyette 05/25/22 Compass Point Compass Point starts SmartRent at Buy, sees 'exponential growth potential' SMRT SmartRent $3.32 / -0.495 (-12.99%) 08/11/22 SmartRent cuts FY22 revenue view to $155M-$180M from $220M-$250M 08/11/22 SmartRent sees Q3 revenue $43M-$47M, consensus $75.4M 08/11/22 SmartRent reports Q2 EPS (13c), consensus (11c) 05/11/22 SmartRent sees FY22 revenue $220M-$250M, consensus $238.1M SMRT SmartRent $3.32 / -0.495 (-12.99%) 08/12/22 What You Missed On Wall Street On Friday 08/12/22 What You Missed On Wall Street This Morning 08/11/22 Fly Intel: After-Hours Movers 05/11/22 Fly Intel: After-Hours Movers
Hot Stocks	Enhabit rises 16.0% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 EHAB Enhabit $16.08 / +2.27 (+16.44%) Enhabit is up 16.0%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly EHAB Enhabit $16.08 / +2.27 (+16.44%) 08/02/22 Enhabit falls -13.9% 08/02/22 Enhabit falls -13.3% 07/05/22 Enhabit to replace Loyalty Ventures in S&P 600 at open on 7/5 07/01/22 Encompass Health completes spin off of Enhabit EHAB Enhabit $16.08 / +2.27 (+16.44%) 08/08/22 Truist Encompass Health price target lowered to $65 from $75 at Truist 07/13/22 BofA BofA starts Enhabit at Underperform on Medicare rate risks 07/13/22 BofA Enhabit initiated with an Underperform at BofA EHAB Enhabit $16.08 / +2.27 (+16.44%) 08/01/22 Enhabit cuts FY22 EPS view to $1.47-$1.75 from $1.64-$2.01 08/01/22 Enhabit reports Q2 EPS 47c vs. 71c last year EHAB Enhabit $16.08 / +2.27 (+16.44%) 08/01/22 Fly Intel: After-Hours Movers 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning

Hot Stocks	Blue Apron rises 20.7% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 APRN Blue Apron $4.60 / +0.795 (+20.89%) Blue Apron is up 20.7%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options APRN Blue Apron $4.60 / +0.795 (+20.89%) 09:47 Today Blue Apron rises 11.5% 08/11/22 Blue Apron introduces new Tailgating Box 'in time for football season' 08/08/22 Blue Apron rises 17.8% 08/08/22 Blue Apron sees a route to revenue acceleration in the second half APRN Blue Apron $4.60 / +0.795 (+20.89%) 08/10/22 Lake Street Blue Apron initiated with a Buy at Lake Street 07/20/22 Benchmark Benchmark starts Blue Apron at Buy with turnaround not getting credit 07/20/22 Benchmark Blue Apron initiated with a Buy at Benchmark 05/10/22 Canaccord Blue Apron price target lowered to $10 from $12 at Canaccord APRN Blue Apron $4.60 / +0.795 (+20.89%) 08/08/22 Blue Apron cuts FY22 revenue growth view to 7%-13% vs. mid-teens 08/08/22 Blue Apron reports Q2 EPS (68c) vs. (98c) a year ago 05/10/22 Blue Apron targets revenue of $700M-plus in 2024 05/09/22 Blue Apron sees FY revenue growth in mid teens, one est. $532.3M APRN Blue Apron $4.60 / +0.795 (+20.89%) 05/10/22 Blue Apron shares going to $10 unless management 'sociopaths,' Citrons says APRN Blue Apron $4.60 / +0.795 (+20.89%) 08/12/22 Short Report: Bed Bath Beyond shorts nudge higher as stock soars 08/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/04/22 Short Report: GameStop short position reaches 15-month high 06/01/22 Fly Intel: After-Hours Movers 08/17/22 August Virtual Micro Cap Conference APRN Blue Apron $4.60 / +0.795 (+20.89%) 09:40 Today Unusually active option classes on open August 15th 07/07/22 Largest borrow rate increases among liquid names 06/24/22 Largest borrow rate increases among liquid names 06/23/22 Largest borrow rate increases among liquid names
Hot Stocks	Revlon rises 22.6% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 REV Revlon $8.05 / +1.48 (+22.53%) Revlon is up 22.6%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Periodicals On The Fly Options REV Revlon $8.05 / +1.48 (+22.53%) 08/09/22 Revlon CFO Victoria Dolan to retire, Matt Kvarda to become interim CFO 07/20/22 Origin Materials, Revlon enter carbon negative material joint initiative 07/01/22 Revlon rises 14.9% 07/01/22 Revlon rises 13.0% REV Revlon $8.05 / +1.48 (+22.53%) 05/04/22 Revlon reports Q1 EPS ($1.14) vs. ($1.55) last year 03/03/22 Revlon reports Q4 EPS 18c, one estimate 6c REV Revlon $8.05 / +1.48 (+22.53%) 06/21/22 Revlon's bankruptcy may be impacted by Citi's $900M error, FT reports 06/17/22 Indian conglomerate Reliance is considering to buy out Revlon, Reuters reports 06/10/22 Revlon preparing Chapter 11 filing as soon as next week, WSJ reports 06/10/22 Revlon nears Chapter 11 filing, WSJ reports, citing sources REV Revlon $8.05 / +1.48 (+22.53%) 08/12/22 Short Report: Bed Bath Beyond shorts nudge higher as stock soars 07/23/22 Short Report: Revlon shorts recede, stock retreats as buyout news fades 07/16/22 Short Report: Canoo shorts going along for the ride 06/18/22 Short Report: Short interest in crypto names spikes as bears pounce on bitcoin REV Revlon $8.05 / +1.48 (+22.53%) 08/02/22 Revlon call volume above normal and directionally bullish 08/02/22 Unusually active option classes on open August 2nd 08/01/22 Revlon call volume above normal and directionally bullish 07/29/22 Largest borrow rate increases among liquid names
Recommendations	Granite Real Estate price target raised to C$100 from C$99 at RBC Capital » 11:59 08/15/22 08/15 11:59 08/15/22 11:59 GRP Granite Real Estate $38.91 / + (+0.00%) RBC Capital analyst Pammi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GRP Granite Real Estate $38.91 / + (+0.00%) 11:37 Today National Bank Granite Real Estate price target raised to C$90 from C$85 at National Bank 07/20/22 National Bank Granite Real Estate price target lowered to C$85 from C$115 at National Bank 05/16/22 Desjardins Granite Real Estate price target lowered to C$104 from C$111 at Desjardins 04/29/22 Scotiabank Granite Real Estate price target raised to C$110 from C$109 at Scotiabank
Recommendations	Akouos files IND for AK-OTOF, says Piper Sandler » 11:59 08/15/22 08/15 11:59 08/15/22 11:59 AKUS Akouos $3.43 / +0.35 (+11.36%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AKUS Akouos $3.43 / +0.35 (+11.36%) 07:04 Today Akouos expects cash to fund operations beyond next eighteen months 05/19/22 Akouos presents nonclinical data on AK-OTOF, microRNA target sites 03/10/22 Akouos appoints Aaron Tward as CSO AKUS Akouos $3.43 / +0.35 (+11.36%) 05/17/22 Piper Sandler Akouos price target lowered to $18 from $40 at Piper Sandler AKUS Akouos $3.43 / +0.35 (+11.36%) 07:04 Today Akouos reports Q2 EPS (58c), consensus (76c) 05/12/22 Akouos reports Q1 EPS (78c), consensus (73c) 03/29/22 Akouos reports Q4 EPS (72c), consensus (66c) AKUS Akouos $3.43 / +0.35 (+11.36%) 08:56 Today Fly Intel: Pre-market Movers
Recommendations	Exchange Income price target raised to C$63 from C$62 at RBC Capital » 11:59 08/15/22 08/15 11:59 08/15/22 11:59 EIFZF Exchange Income $38.22 / +0.88 (+2.36%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EIFZF Exchange Income $38.22 / +0.88 (+2.36%) 11:36 Today National Bank Exchange Income price target raised to C$61 from C$59 at National Bank 11:01 Today Scotiabank Exchange Income price target raised to C$60 from C$56 at Scotiabank 10:52 Today TD Securities Exchange Income price target raised to C$67 from C$59 at TD Securities 05/17/22 RBC Capital Exchange Income price target raised to C$62 from C$52 at RBC Capital
Recommendations	ECN Capital price target raised to C$8 from C$7.50 at RBC Capital » 11:57 08/15/22 08/15 11:57 08/15/22 11:57 ECNCF ECN Capital $5.57 / +0.384 (+7.40%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ECNCF ECN Capital $5.57 / +0.384 (+7.40%) 08/12/22 BMO Capital ECN Capital price target raised to C$8 from C$7 at BMO Capital 08/12/22 Raymond James ECN Capital price target raised to C$8 from C$7 at Raymond James 08/12/22 National Bank ECN Capital price target raised to C$8.50 from C$8 at National Bank 08/09/22 TD Securities ECN Capital price target raised to C$8.50 from C$8 at TD Securities
Recommendations	Dialogue Health price target lowered to C$6 from C$7 at RBC Capital » 11:57 08/15/22 08/15 11:57 08/15/22 11:57 DLHTF Dialogue Health $2.30 / + (+0.00%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DLHTF Dialogue Health $2.30 / + (+0.00%) 08/12/22 Scotiabank Dialogue Health price target lowered to C$8 from C$8.50 at Scotiabank 08/12/22 TD Securities Dialogue Health price target lowered to C$4.50 from C$5.50 at TD Securities 08/09/22 National Bank Dialogue Health price target lowered to C$8.50 from C$11.50 at National Bank
Recommendations	Chemtrade Logistics price target raised to C$10 from C$9 at RBC Capital » 11:56 08/15/22 08/15 11:56 08/15/22 11:56 CGIFF Chemtrade Logistics $7.17 / +0.06 (+0.84%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CGIFF Chemtrade Logistics $7.17 / +0.06 (+0.84%) 11:34 Today National Bank Chemtrade Logistics price target raised to C$11 from C$9.25 at National Bank 11:15 Today Desjardins Chemtrade Logistics price target raised to C$11.75 from C$11 at Desjardins 08/12/22 BMO Capital Chemtrade Logistics price target raised to C$9 from C$8 at BMO Capital 08/12/22 Scotiabank Chemtrade Logistics price target raised to C$10.50 from C$10.25 at Scotiabank
Hot Stocks	Novartis' treatment of Malaria granted FDA orphan designation » 11:56 08/15/22 08/15 11:56 08/15/22 11:56 NVS Novartis $85.05 / -0.63 (-0.74%) Novartis… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NVS Novartis $85.05 / -0.63 (-0.74%) 05:13 Today Novartis announces CANOPY-A trial did not meet primary endpoint 08/11/22 FDA grants regular approval to Novartis' capmatinib for metastatic NSCLC 08/08/22 Chimerix appoints Jordan as VP, Regulatory Affairs 07/28/22 Bausch Health to appeal expected court decision on certain Xifaxan patents NVS Novartis $85.05 / -0.63 (-0.74%) 08/05/22 Truist Global Blood could complement any oncology franchise, says Truist 08/04/22 Truist Truist sees Novartis, Vertex as logical suitors for Global Blood 07/20/22 JPMorgan Novartis price target raised to CHF 81 from CHF 80 at JPMorgan 07/20/22 Piper Sandler Piper adjusts Ionis' Spinraza royalties estimate following Biogen report NVS Novartis $85.05 / -0.63 (-0.74%) 07/19/22 Novartis reports Q2 core EPS $1.56 vs. $1.66 a year ago 04/26/22 Novartis sees 2022 core operating income to grow mid single digit 04/26/22 Novartis reports Q1 core EPS $1.46, consensus $1.46 NVS Novartis $85.05 / -0.63 (-0.74%) 08/11/22 Two died from acute liver failure after use of Novartis' Zolgensma, STAT says 06/30/22 Novartis favoring spinoff of $25B Sandoz unit, Bloomberg reports 06/30/22 Novartis said to lean toward Sandoz spinoff over sale, Bloomberg says 06/28/22 Novartis to cut up to 8,000 jobs, or 7% of workforce, in restructuring NVS Novartis $85.05 / -0.63 (-0.74%) 08/12/22 What You Missed On Wall Street This Morning 06/30/22 What You Missed On Wall Street On Thursday 06/30/22 What You Missed On Wall Street This Morning 06/28/22 What You Missed On Wall Street On Tuesday 09/10/22 ESMO Congress 2022 09/19/22 Novartis NVS Novartis $85.05 / -0.63 (-0.74%) 08/09/22 Largest borrow rate increases among liquid names
Recommendations	AG Growth International price target raised to C$55 from C$50 at RBC Capital » 11:56 08/15/22 08/15 11:56 08/15/22 11:56 AGGZF AG Growth International $30.82 / +1.01285 (+3.40%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AGGZF AG Growth International $30.82 / +1.01285 (+3.40%) 11:11 Today Desjardins AG Growth International price target raised to C$53 from C$48 at Desjardins 08/12/22 Scotiabank AG Growth International price target raised to C$55 from C$52 at Scotiabank 04/20/22 Scotiabank AG Growth International price target raised to C$52 from C$50 at Scotiabank 03/17/22 RBC Capital AG Growth International price target raised to C$50 from C$45 at RBC Capital

Hot Stocks	Take-Two's Private Division to publish Middle-Earth game » 11:54 08/15/22 08/15 11:54 08/15/22 11:54 TTWO Take-Two $127.36 / +4.22 (+3.43%) Take-Two's Private… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TTWO Take-Two $127.36 / +4.22 (+3.43%) 09:06 Today Take-Two unit Private Division in publishing pact with Weta Workshop 08/09/22 Take-Two CEO: We're very confident in our upcoming titles 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/02/22 U.S. video game consumer spending fell 13% y/y in Q2, says NPD TTWO Take-Two $127.36 / +4.22 (+3.43%) 08/10/22 DZ Bank Take-Two downgraded to Hold from Buy at DZ Bank 08/09/22 BofA BofA downgrades Take-Two, says risk/reward less appealing after Zynga deal 08/09/22 BofA Take-Two downgraded to Neutral from Buy at BofA 08/09/22 Oppenheimer Take-Two price target lowered to $180 from $190 at Oppenheimer TTWO Take-Two $127.36 / +4.22 (+3.43%) 08/08/22 Take-Two sees FY23 revenue $5.73B-$5.8B, consensus $6.32B 08/08/22 Take-Two reports Q2 EPS (76c) vs. $1.30 last year 05/16/22 Take-Two sees Q1 GAAP EPS 80c-90c, consensus 90c 05/16/22 Take-Two sees FY23 GAAP EPS $1.90-$2.15, consensus $5.99 TTWO Take-Two $127.36 / +4.22 (+3.43%) 07/21/22 Europe game sales rose 13.5% year-over-year in 1H22, Gamesindustry.biz says 07/11/22 Rockstar shelved plans for 'Red Dead 2' next-gen upgrade, VGC reports 07/05/22 Take-Two's Rockstar halts development of 'Red Dead,' 'GTA4' remakes, Kotaku says 04/14/22 'Elden Ring' top-selling game in Europe in March, Gamesindustry.biz says TTWO Take-Two $127.36 / +4.22 (+3.43%) 08/09/22 What You Missed This Week in Video Games 08/02/22 What You Missed This Week in Video Games 07/26/22 What You Missed This Week in Video Games 07/19/22 What You Missed This Week in Video Games 09/08/22 Consumer/Media/Entertainment Conference 09/16/22 Take-Two Interactive Software Inc. TTWO Take-Two $127.36 / +4.22 (+3.43%) 06/07/22 Early notable gainers among liquid option names on June 7th 05/25/22 Notable open interest changes for May 25th 05/17/22 Early notable gainers among liquid option names on May 17th 04/22/22 TakeTwo Interactive Software call volume above normal and directionally bullish
Hot Stocks	Taseko Mines reports EPA issues draft permit for Florence Copper Project » 11:54 08/15/22 08/15 11:54 08/15/22 11:54 TGB Taseko Mines $1.20 / +0.11 (+10.09%) Taseko Mines announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options TGB Taseko Mines $1.20 / +0.11 (+10.09%) 07/07/22 Taseko Mines updates status of copper price protection program 03/30/22 Taseko Mines announces 40% increase in Gibraltal Mine reserves TGB Taseko Mines $1.20 / +0.11 (+10.09%) 08/10/22 Scotiabank Taseko Mines price target lowered to C$1.75 from C$2 at Scotiabank 08/10/22 TD Securities Taseko Mines price target lowered to C$2.25 from C$2.50 at TD Securities 08/09/22 BMO Capital Taseko Mines price target lowered to C$2.50 from C$2.75 at BMO Capital 07/19/22 Stifel Taseko Mines price target lowered to C$2.50 from C$3.40 at Stifel TGB Taseko Mines $1.20 / +0.11 (+10.09%) 02/22/22 Taseko Mines options imply 11.3% move in share price post-earnings
Recommendations	Viridian Therapeutics price target raised to $50 from $40 at Evercore ISI » 11:51 08/15/22 08/15 11:51 08/15/22 11:51 VRDN Viridian Therapeutics $23.74 / +8.855 (+59.51%) Evercore ISI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events VRDN Viridian Therapeutics $23.74 / +8.855 (+59.51%) 09:42 Today Viridian Therapeutics trading resumes 09:37 Today Viridian Therapeutics trading halted, volatility trading pause 07:07 Today Viridian Therapeutics- VRDN-001 shows efficacy in Phase 1/2 trial for TED 08/05/22 Viridian Therapeutics announces inducement grants under Nasdaq listing rule VRDN Viridian Therapeutics $23.74 / +8.855 (+59.51%) 06/23/22 B. Riley B. Riley starts Viridian Therapeutics at Buy with $25 price target 06/23/22 B. Riley Viridian Therapeutics initiated with a Buy at B. Riley 11/18/21 SVB Leerink Viridian Therapeutics initiated with an Outperform at SVB Leerink 11/05/21 JMP Securities Viridian Therapeutics price target lowered to $36 from $44 at JMP Securities VRDN Viridian Therapeutics $23.74 / +8.855 (+59.51%) 07:17 Today Viridian Therapeutics reports Q2 EPS ($1.06), consensus (90c) 05/12/22 Viridian Therapeutics reports Q1 EPS (98c), consensus ($1.08) 03/10/22 Viridian Therapeutics reports Q4 EPS ($1.32), consensus (90c) 21 Sep VRDN Viridian Therapeutics $23.74 / +8.855 (+59.51%) 08:56 Today Fly Intel: Pre-market Movers 08:00 Today Viridian Therapeutics - VRDN
General news	Treasury's $96 B 3- and 6-month auction results were generally poor » 11:50 08/15/22 08/15 11:50 08/15/22 11:50 $ECON Economic Data $0.00 / + (+0.00%) Treasury's $96 B 3-… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data $0.00 / + (+0.00%) 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data $0.00 / + (+0.00%) $ECON Economic Data $0.00 / + (+0.00%) 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data $0.00 / + (+0.00%) 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data $0.00 / + (+0.00%) 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Periodicals	Sony's 'Horizon Forbidden West' still top seller in U.K., Gamesindustry.biz says » 11:48 08/15/22 08/15 11:48 08/15/22 11:48 SGAMY Sega Sammy Holdings $3.78 / +0.052 (+1.39%) , SONY Sony $86.65 / -0.1 (-0.12%) , NTDOY Nintendo $53.94 / + (+0.00%) , MSFT Microsoft $291.77 / -0.1 (-0.03%) , WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) Sega's (SGAMY)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SGAMY SONY NTDOY MSFT WBD SGAMY Sega Sammy Holdings $3.78 / +0.052 (+1.39%) 07/15/22 Bandai Namco's 'Elden Ring' best selling game in U.S. in June, says NPD 07/13/22 Sega Genesis Mini 2 out October 27, available exclusively through Amazon 04/20/22 Sega says remastered 'Sonic the Hedgehog' collection out June 23, 2022 03/11/22 Bandai Namco's 'Elden Ring' best-selling game in U.S. in February, says NPD SONY Sony $86.65 / -0.1 (-0.12%) 08/12/22 Warner Bros. Discovery's 'Hogwarts Legacy' game out February 10, 2023 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/07/22 Fly Intel: Top five weekend stock stories 08/02/22 U.S. video game consumer spending fell 13% y/y in Q2, says NPD NTDOY Nintendo $53.94 / + (+0.00%) 08/12/22 Warner Bros. Discovery's 'Hogwarts Legacy' game out February 10, 2023 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/03/22 Nintendo sold 3.43M Switch consoles in Q1 vs. 4.45M last year 08/02/22 U.S. video game consumer spending fell 13% y/y in Q2, says NPD MSFT Microsoft $291.77 / -0.1 (-0.03%) 08/12/22 Warner Bros. Discovery's 'Hogwarts Legacy' game out February 10, 2023 08/09/22 Barclays deploys Microsoft teams as collaboration platform 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/04/22 Atlassian names Microsoft's Joe Binz as new CFO WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 07:16 Today Nexstar to acquire 75% ownership in The CW Network 08/12/22 Warner Bros. Discovery's 'Hogwarts Legacy' game out February 10, 2023 08/04/22 Warner Bros. Discovery backs long-term leverage target of 2.5-3.0 08/04/22 Warner Bros. Discovery sees FY23 adjusted EBITDA of 'at least $12B' SGAMY SONY NTDOY MSFT WBD SGAMY Sega Sammy Holdings $3.78 / +0.052 (+1.39%) SONY Sony $86.65 / -0.1 (-0.12%) 07/08/22 Macquarie Sony upgraded to Outperform, added to 'Marquee Buy' list at Macquarie 07/05/22 Citi Sony downgraded to Neutral from Buy at Citi 05/18/22 Oppenheimer Sony price target lowered to $125 from $150 at Oppenheimer 04/13/22 CLSA Sony downgraded to Outperform from Buy at CLSA NTDOY Nintendo $53.94 / + (+0.00%) 05/24/22 CLSA Nintendo price target lowered to 51,000 yen from 53,000 yen at CLSA 03/23/22 Macquarie Nintendo upgraded to Outperform from Neutral at Macquarie 02/16/22 Jefferies Nintendo upgraded to Buy from Hold at Jefferies 11/05/21 Macquarie Nintendo downgraded to Neutral from Outperform at Macquarie MSFT Microsoft $291.77 / -0.1 (-0.03%) 08/11/22 Guggenheim Microsoft initiated with a Neutral at Guggenheim 08/08/22 B. Riley B. Riley thinks Globalstar's mystery satellite capacity customer is Apple 08/04/22 MKM Partners 8x8 initiated with a Neutral at MKM Partners 08/04/22 Deutsche Bank Activision Blizzard price target lowered to $84 from $95 at Deutsche Bank WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 08/11/22 Wells Fargo Disney price target raised to $145 from $130 at Wells Fargo 08/10/22 Oppenheimer Trade Desk price target raised to $78 from $60 at Oppenheimer 08/08/22 Barrington Warner Bros. Discovery downgraded to Market Perform from Outperform at Barrington 08/05/22 Wells Fargo Warner Bros. Discovery downgraded to Equal Weight at Wells Fargo SONY NTDOY MSFT WBD SONY Sony $86.65 / -0.1 (-0.12%) 07/29/22 Sony raises FY22 consolidated sales view Y11.5T from Y11.4T 07/29/22 Sony reports Q1 revenue Y2.31T vs. Y2.26T last year 05/10/22 Sony sees FY22 consolidated sales Y11.4T vs. Y9.921B in FY21 05/10/22 Sony reports FY21 revenue Y9.921B vs. Y8.998B last year NTDOY Nintendo $53.94 / + (+0.00%) 08/03/22 Nintendo sees FY net sales Y1.6T, operating profit Y500B 08/03/22 Nintendo reports Q1 revenue Y307.46B vs. Y322.65B last year 05/10/22 Nintendo reports FY revenue Y1.70T vs. Y1.8T last year MSFT Microsoft $291.77 / -0.1 (-0.03%) 07/26/22 Microsoft sees FY23 revenue growth in double digits, consensus $225.98B 07/26/22 Microsoft reports Q4 EPS $2.23, consensus $2.30 07/26/22 Notable companies reporting after market close 06/02/22 Microsoft lowers Q4 EPS view to $2.24-$2.32 from $2.28-$2.35, consensus $2.33 WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 08/04/22 Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B 08/04/22 Warner Bros. Discovery reports Q2 EPS with items ($1.50), consensus (3c) 08/04/22 Notable companies reporting after market close 04/26/22 Warner Bros. Discovery reports Q1 diluted EPS 69c vs. 21c a year ago SGAMY SONY NTDOY MSFT WBD SGAMY Sega Sammy Holdings $3.78 / +0.052 (+1.39%) 06/30/22 Sega eyes further expansion into live-action films, TV shows, IGN reports 04/19/22 Sega working on AAA reboots of 'Crazy Taxi,' 'Jet Set Radio,' Bloomberg says 04/04/22 'Sonic 2' film amasses $25.5M internationally, Gamesindustry.biz says SONY Sony $86.65 / -0.1 (-0.12%) 08/11/22 Game console sales fall 16% m/m in the U.K. in July, Gamesindustry.biz reports 08/11/22 Microsoft claims Sony pays developers to not put games on Game Pass, VGC says 08/10/22 Microsoft dismisses Sony claim that Activision deal is anticompetitive, VGC says 08/08/22 'Horizon Forbidden West' retakes top sales spot in U.K., Gamesindustry.biz says NTDOY Nintendo $53.94 / + (+0.00%) 08/11/22 Game console sales fall 16% m/m in the U.K. in July, Gamesindustry.biz reports 08/10/22 NLRB receives new workplace complaint against Nintendo, Axios reports 08/08/22 'Horizon Forbidden West' retakes top sales spot in U.K., Gamesindustry.biz says 08/04/22 Nintendo not releasing new hardware this fiscal year, Nikkei reports MSFT Microsoft $291.77 / -0.1 (-0.03%) 08/11/22 Game console sales fall 16% m/m in the U.K. in July, Gamesindustry.biz reports 08/11/22 Microsoft claims Sony pays developers to not put games on Game Pass, VGC says 08/10/22 Microsoft dismisses Sony claim that Activision deal is anticompetitive, VGC says 08/09/22 Microsoft lays off staff in Modern Life Experiences business, TechCrunch says WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 08/08/22 'Horizon Forbidden West' retakes top sales spot in U.K., Gamesindustry.biz says 08/05/22 Warner Bros. Discovery exploring free, ad-supported streaming, WSJ reports 08/04/22 Warner Bros. Discovery to combine HBO Max, Discovery+ next summer, Verge says 08/04/22 Warner Bros. Discovery to restructure HBO Max, Discovery+, TheWrap reports SGAMY SONY NTDOY MSFT WBD SGAMY Sega Sammy Holdings $3.78 / +0.052 (+1.39%) 07/19/22 What You Missed This Week in Video Games 07/12/22 What You Missed This Week in Video Games 06/28/22 What You Missed This Week in Video Games 06/22/22 What You Missed This Week in Video Games SONY Sony $86.65 / -0.1 (-0.12%) 08/09/22 What You Missed This Week in Video Games 08/07/22 Box Office Battle: ‘Bullet Train’ wins weekend with $30.1M debut 08/02/22 What You Missed This Week in Video Games 07/31/22 Box Office Battle: ‘DC League of Super-Pets’ wins weekend with $23M debut NTDOY Nintendo $53.94 / + (+0.00%) 08/09/22 What You Missed This Week in Video Games 08/02/22 What You Missed This Week in Video Games 07/26/22 What You Missed This Week in Video Games 07/19/22 What You Missed This Week in Video Games MSFT Microsoft $291.77 / -0.1 (-0.03%) 08/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/09/22 What You Missed On Wall Street On Tuesday 08/09/22 What You Missed This Week in Video Games 08/02/22 What You Missed This Week in Video Games WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 08/12/22 Sell these stocks now, proven algorithm says 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations MSFT WBD MSFT Microsoft $291.77 / -0.1 (-0.03%) 07/28/22 Notable open interest changes for July 28th 07/26/22 Microsoft options imply 4.7% move in share price post-earnings 06/03/22 Unusually active option classes on open June 3rd 06/02/22 Unusually active option classes on open June 2nd WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 08/12/22 Warner Bros Discovery Inc put volume heavy and directionally bearish 08/11/22 Early notable gainers among liquid option names on August 11th 08/09/22 Warner Bros Discovery Inc put volume heavy and directionally bearish 08/05/22 Notable open interest changes for August 5th

Events

Earnings calls, analyst events, roadshows and more

HCDI
Today at 12:30

Harbor Custom Development - HCDI Conference Calls
MCHP
Today at 13:00

Microchip - MCHP Conference Calls
BDC
Today at 13:00

Belden - BDC Conference Calls
DGX
Today at 13:00

Quest Diagnostics - DGX Conference Calls
REKR
Today at 13:00

Rekor Systems Inc Firm Sponsored Meetings

6721 Columbia Gateway Dr Suite 400, Columbia, MD
Today at 13:00

Natural Resources Industry Meetings
EBR
Today at 13:30

Eletrobras - EBR Conference Calls
DXYN
Today at 14:00

Dixie Group - DXYN Conference Calls
Today at 16:00

Treasury Int'l Capital: Net L-T Securities Transactions: June 2022 Government Event
TTOO
Today at 16:30

T2 Biosystems - TTOO Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	LUCY X LUCY Innovative Eyewear IPO Managers: Maxim Priced at: $7.50 980K Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	GRFX X GRFX Graphex Group Secondary Managers: EF Hutton $2.00-3.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	GFRX X GFRX Graphex Group Secondary Managers: EF Hutton $2.00-3.00 8M Shares
Fri	No deals

View All Syndicate Announcements »

Group 1 Automotive downgraded to Underweight from Equal Weight at Morgan Stanley

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access